Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
Article in Journal of Biomedical Science (January 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Journal of Biomedical Science (January 2024)
Article in OncoImmunology (March 2018)
Book chapter (April 2017)